| Display title | Chemistry:CUMYL-THPINACA |
| Default sort key | CUMYL-THPINACA |
| Page length (in bytes) | 3,697 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 31668 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Len Stevenson |
| Date of page creation | 03:19, 26 November 2022 |
| Latest editor | imported>Len Stevenson |
| Date of latest edit | 03:19, 26 November 2022 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors. |
